Out-licensing

Slim & Slim PWH which can reduce body fat, blood lipids, blood glucose and fatty-liver condition.

Supporting Evidence (Efficacy/Functionality):

 

Provide all supporting literature and research studies, publications, protocols, and analytical assessment.

Please separate data into:

o        Mechanism of Action/s (MOA)

: Lipase, ACAT, HMG-CoA reductase inhibition, appetite reduction, leptin increase

steroid excretion increase.

o        Chemistry/Characterization data

o        In vitro bioassaydata

o        In vivo testing (Laboratory, Animal, and Human Clinical Studies)

o        In vivo testing

: See the attached material publications.

o        Clinically tested : Naringin / hesperidin

§  Provide studies done by Company on the ingredient. : See the attached. brochure

§  Total number of clinical studies completed? : 1

§  Study design? (number of subjects, duration of the study/ies, double-blinded, placebo-controlled, case controlled, etc.) : 9

§  Percent response rate?  : 100%

§  Dose and delivery form used in the study/ies : 500mg/capsule

o        Published or not published, and in which journal/s?

o        Recommended Delivery form/s? : 500mg/capsule

o        Recommended dose/s? (mg per day) : 500mg/Day

o        Collaborating Organizations, professors or University Affiliations

: Seoul National Univ. Medical School& --- Prof. Park, Young Bae

o        Conclusions from the studies: Good for cholesterol lowering.

Early Stage

Provide an IP Portfolio summary to include : See the attached.

o        Provide patent information

§  Provisional/non-provisional/PCT/

§  How is the patent unique, compared to competition?

§  Number of patents?

§  Patent Type? (Process, Application, Combination, Composition, or other)

§  Patent Number/s, title, abstract, claims and application/issue dates

o        Describe exclusivity options : global (possible)